Topic

North Carolina

A collection of 524 issues

How to Get Cimzia (Certolizumab Pegol) Covered by Aetna (CVS Health) in North Carolina: Complete Appeals Guide and Timeline

Answer Box: Getting Cimzia Covered by Aetna in North Carolina Eligibility: Cimzia requires prior authorization from Aetna (CVS Health) for all patients. You must have documented failure or intolerance to preferred alternatives and complete TB/hepatitis B screening. Fastest path: Submit complete prior authorization with medical necessity letter, screening results,
6 min read

Getting Tagrisso (Osimertinib) Covered by Cigna in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Quick Path to Approval Cigna requires prior authorization for Tagrisso (osimertinib) with documented EGFR mutation testing and oncologist prescribing. Fastest approval path: Submit PA through Express Scripts/Accredo with EGFR mutation results, pathology report, and medical necessity letter. If denied, file internal appeal within 180 days, then request
6 min read

UnitedHealthcare's Coverage Criteria for Darzalex (Daratumumab) in North Carolina: Complete Medical Necessity Guide

Answer Box: Getting Darzalex Covered by UnitedHealthcare in North Carolina UnitedHealthcare requires prior authorization for Darzalex (daratumumab) with specific medical necessity criteria: confirmed multiple myeloma diagnosis, appropriate treatment line documentation, and FDA-approved or NCCN guideline-supported regimens. Submit PA requests through the UnitedHealthcare Provider Portal with complete clinical documentation. If denied,
6 min read

How to Get Isturisa (Osilodrostat) Covered by Aetna CVS Health in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Isturisa Covered by Aetna CVS Health in North Carolina Fastest path to approval: Submit Aetna's specialty medication prior authorization form through the Availity provider portal with complete documentation: confirmed Cushing's disease diagnosis, failed pituitary surgery or contraindication, and prescription from an endocrinologist. Standard
6 min read

How to Get Retevmo (Selpercatinib) Covered by Blue Cross Blue Shield in North Carolina: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Retevmo Covered by BCBS North Carolina Blue Cross Blue Shield of North Carolina requires prior authorization for Retevmo (selpercatinib) for RET fusion-positive NSCLC and thyroid cancers. You'll need FDA-approved RET testing results, pathology reports, and clinical documentation. If denied, file internal appeals within 180 days,
5 min read

How to Get Idelvion (albutrepenonacog alfa) Covered by Humana in North Carolina: Prior Authorization, Appeals, and Medical Necessity Guide

Answer Box: Getting Idelvion Covered by Humana in North Carolina Idelvion requires prior authorization from Humana Medicare Advantage plans in North Carolina. You'll need confirmed hemophilia B diagnosis (Factor IX <40%), documented step therapy attempts with standard products, and clinical justification for extended half-life therapy. Start today:
5 min read

How to Get Elaprase (Idursulfase) Covered by Aetna (CVS Health) in North Carolina: Complete Appeals Guide with Forms and Timelines

Answer Box: Fast Track to Elaprase Coverage To get Elaprase (idursulfase) covered by Aetna (CVS Health) in North Carolina: Submit the Aetna Elaprase Precertification Form with enzymatic/genetic test results confirming Hunter syndrome diagnosis, current weight documentation, and specialist attestation. If denied, appeal internally within 180 days, then file for
6 min read

How to Get Pemazyre (pemigatinib) Covered by Humana in North Carolina: Complete Guide to Prior Authorization, Appeals, and Approval

Answer Box: Fastest Path to Pemazyre Coverage Pemazyre (pemigatinib) requires prior authorization from Humana in North Carolina. You'll need documented FGFR2 fusion/rearrangement testing, baseline ophthalmologic monitoring plan, and proof of prior systemic therapy failure. Submit complete documentation through Humana's provider portal for 72-hour standard review.
6 min read